ES2137981T3 - Tratamiento combinado por agentes antimediaticos y antiviricos de resfriados comunes. - Google Patents

Tratamiento combinado por agentes antimediaticos y antiviricos de resfriados comunes.

Info

Publication number
ES2137981T3
ES2137981T3 ES93900648T ES93900648T ES2137981T3 ES 2137981 T3 ES2137981 T3 ES 2137981T3 ES 93900648 T ES93900648 T ES 93900648T ES 93900648 T ES93900648 T ES 93900648T ES 2137981 T3 ES2137981 T3 ES 2137981T3
Authority
ES
Spain
Prior art keywords
cold
agents
antiinflammatory
antiviral
severity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93900648T
Other languages
English (en)
Inventor
Jack M Gwaltney Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Virginia UVA
University of Virginia Patent Foundation
Original Assignee
University of Virginia UVA
University of Virginia Patent Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/794,520 external-priority patent/US5240694A/en
Application filed by University of Virginia UVA, University of Virginia Patent Foundation filed Critical University of Virginia UVA
Application granted granted Critical
Publication of ES2137981T3 publication Critical patent/ES2137981T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Abstract

EL RESFRIADO COMUN Y LOS DESORDENES RELACIONADOS COMO GRIPE, SINUSITIS AGUDA, OTITIS AGUDA Y EXACERBACIONES INFECCIOSAS DE ENFERMEDAD PULMONAR OBSTRUSIVA SE TRATAN DE FORMA EFECTIVA SUMINISTRANDO UNA COMBINACION DE AGENTES ANTIVIRICOS Y COMPONENTES ANTIINFLAMATORIOS AL PACIENTE INFECTADO CON UN VIRUS DE GRIPE O RESFRIADO. UN AGENTE ANTIVIRICO Y DOS COMPONENTES ANTIINFLAMATORIOS SUMINISTRADOS A UN PACIENTE INFECTADO CON EL VIRUS DEL RESFRIADO REDUCE SIMULTANEAMENTE LA PROBABILIDAD DE DESARROLLAR UN RESFRIADO Y LA CANTIDAD Y DURACION DE LA EFUSION VIRICA Y DISMINUYE LA SEVERIDAD DE LOS SINTOMAS INDIVIDUALES DE RESFRIADO Y EL NUMERO TOTAL Y SEVERIDAD DE LOS SINTOMAS DEL RESFRIADO. COMPLEMENTANDO LA ACTIVIDAD DE LOS AGENTES ANTIVIRICOS Y ANTIINFLAMATORIOS COMBINADOS CON COMPONENTES TALES COMO ANTIHISTAMINAS Y AGONISTAS ALFA SE OBTIENEN BENEFICIOS NASALES SORPRENDENTEMENTE BUENOS. LA TERAPIA DE COMBINACION, DENOMINADA TERAPIA COVAM, SE TOLERA BIEN Y NO EVIDENCIA TOXICIDAD A CORTO PLAZO.
ES93900648T 1991-11-19 1992-11-18 Tratamiento combinado por agentes antimediaticos y antiviricos de resfriados comunes. Expired - Lifetime ES2137981T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/794,520 US5240694A (en) 1991-09-23 1991-11-19 Combined antiviral and antimediator treatment of common colds
US82389192A 1992-01-22 1992-01-22
PCT/US1992/010170 WO1993009764A1 (en) 1991-11-19 1992-11-18 Combined virustatic antimediator (covam) treatment of common colds

Publications (1)

Publication Number Publication Date
ES2137981T3 true ES2137981T3 (es) 2000-01-01

Family

ID=27121512

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93900648T Expired - Lifetime ES2137981T3 (es) 1991-11-19 1992-11-18 Tratamiento combinado por agentes antimediaticos y antiviricos de resfriados comunes.

Country Status (7)

Country Link
EP (1) EP0661967B1 (es)
JP (1) JPH08508007A (es)
AT (1) ATE183640T1 (es)
CA (1) CA2122719A1 (es)
DE (1) DE69229880T2 (es)
ES (1) ES2137981T3 (es)
WO (1) WO1993009764A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5492689A (en) * 1991-11-19 1996-02-20 The Center For Innovative Technology Combined virustatic antimediator (COVAM) treatment of common colds
CA2227958A1 (en) * 1995-07-28 1997-02-13 Sekhar Mitra Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
CN1253508A (zh) * 1997-04-30 2000-05-17 沃尼尔－朗伯公司 局部鼻用抗炎组合物
PL208686B1 (pl) * 2001-09-18 2011-05-31 Nycomed Danmark Aps Kompozycja w postaci roztworu wodnego do leczenia przeziębienia oraz zastosowanie połączenia ipratropium lub jego soli i ksylometazoliny lub jej soli
ES2235655B1 (es) * 2003-12-29 2006-03-16 Hartington Business, S.L. Extracto aislado de una planta de cyclamen europaeum l. como agente terapeutico.
DE102004049008A1 (de) 2004-10-05 2006-04-06 Merck Patent Gmbh Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
SE0950633L (sv) * 2006-03-14 2009-09-03 Wholesome Biopharm Pty Ltd Metod och komposition för behandling av allergiska sjukdomar
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
ES2442024T3 (es) 2008-07-15 2014-02-07 Academia Sinica Matrices de glucano sobre portaobjetos de vidrio revestidos con aluminio de tipo PTFE y métodos relacionados
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
US10130714B2 (en) * 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
US9914956B2 (en) 2012-08-18 2018-03-13 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
EP3013365B1 (en) 2013-06-26 2019-06-05 Academia Sinica Rm2 antigens and use thereof
WO2014210564A1 (en) 2013-06-27 2014-12-31 Academia Sinica Glycan conjugates and use thereof
CA2923579C (en) 2013-09-06 2023-09-05 Academia Sinica Human inkt cell activation using glycolipids with altered glycosyl groups
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
AU2015206370A1 (en) 2014-01-16 2016-07-07 Academia Sinica Compositions and methods for treatment and detection of cancers
CN106415244B (zh) 2014-03-27 2020-04-24 中央研究院 反应性标记化合物及其用途
EP3149037A4 (en) 2014-05-27 2018-01-10 Academia Sinica Anti-her2 glycoantibodies and uses thereof
KR20220151036A (ko) 2014-05-27 2022-11-11 아카데미아 시니카 항-ｃｄ20 글리코항체 및 이의 용도
KR20230033737A (ko) 2014-05-27 2023-03-08 아카데미아 시니카 증진된 항체 효능을 위한 범용 당형태에 관한 조성물 및 방법
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
KR102494193B1 (ko) 2014-05-28 2023-01-31 아카데미아 시니카 항-ｔｎｆ-알파 글리코항체 및 이의 용도
WO2016040369A2 (en) 2014-09-08 2016-03-17 Academia Sinica HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
CA2972072A1 (en) 2015-01-24 2016-07-28 Academia Sinica Novel glycan conjugates and methods of use thereof
JP2019515876A (ja) 2016-03-08 2019-06-13 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ Ｎ−グリカンおよびそのアレイのモジュール合成のための方法
JP7213549B2 (ja) 2016-08-22 2023-01-27 シーエイチオー ファーマ インコーポレイテッド 抗体、結合性断片、および使用の方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4269842A (en) * 1979-12-05 1981-05-26 Rhone-Poulenc Industries Method for treating rhinoviral complaints
EP0311616B1 (en) * 1986-06-17 1991-09-25 Biogen, Inc. Combinations of gamma interferons and anti-inflammatory or anti-pyretic agents for treating diseases
US5137876A (en) * 1990-10-12 1992-08-11 Merck & Co., Inc. Nucleoside antiviral and anti-inflammatory compounds and compositions and methods for using same

Also Published As

Publication number Publication date
WO1993009764A1 (en) 1993-05-27
EP0661967A4 (en) 1994-09-29
JPH08508007A (ja) 1996-08-27
EP0661967A1 (en) 1995-07-12
DE69229880D1 (de) 1999-09-30
EP0661967B1 (en) 1999-08-25
CA2122719A1 (en) 1993-05-27
ATE183640T1 (de) 1999-09-15
DE69229880T2 (de) 2000-05-04

Similar Documents

Publication Publication Date Title
ES2137981T3 (es) Tratamiento combinado por agentes antimediaticos y antiviricos de resfriados comunes.
DE69025834D1 (de) Antivirale Verbindungen
HUP0004170A2 (hu) Eljárás és anyagok nyálkaszövetek gyulladásának kezelésére és megelőzésére
BR9810745A (pt) Derivados de benzimidazol
TW371660B (en) Therapeutic nucleosides a purine carbocyclic nucleosides for treatment of HIV and HBV infections
ES2010786A6 (es) Metodo para preparar nuecleosidos y nucleotidos mejoradores del sistema antiviral, antitumoral, antimetastatico e inmune.
BR0214944A (pt) Nucleosìdeos de n4-acilcitosina para o tratamento de infecções virais
CO5200855A1 (es) Uso de csaids en infecciones por rinovirus
SE9602931D0 (sv) New medicinal use
KR950701820A (ko) 패혈증 및 패혈증-연관 옹고장애의 예방 및 치료(prophylaxs and treatment of sepsis and sepsis-associated coagulation disorders)
DK178188A (da) Antivirusmiddel
BR9712614A (pt) Composição farmacêutica,processos para aumentar e manter a homogeneidade de uma composição farmac&eutica,para tratar,reverter,reduzir ou inibir infeccões retrovirais e para preparação de uma composição farmacêutica,uso de lamivudina ou de um derivado farmaceuticamenete aceitável da mesma,de zidovudina,ou de um derivado farmaceuticamente aceitável da mesma e de um agente de deslizamento farmaceuticamente aceitável,e, artigo de amnufatura.
ES2166752T3 (es) Asociacion entre un retrovirus relacionado con el virus de inmunodeficiencia humana y el sindrome de sjogren.
ATE183508T1 (de) Therapeutische nukleoside
MX9303985A (es) Nucleosidos terapeuticos.
Minor et al. Sinusitis and asthma
ATE112489T1 (de) Extrakte von acanthospermum hispidum-pflanzen.
NO171168C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antivirale forbindelser
ES2078380T3 (es) Oligofosfatos de accion antiviral.
RU94016333A (ru) Лекарственное средство для лечения вирусных заболеваний
Brown LV Intrasinal Application of Sulfonamide Powder
NO962848L (no) Monohydrat av (E)-2'-deoksy-2'-(fluormetylen)cytidin
Prober Ribavirin: A new weapon against respiratory viruses?.
Kido et al. Fracture of the Femoral Neck Following Pelvic Irradiation
BR0016844A (pt) Tratamento de infecção de vìrus de imunodeficiência humana resistente a drogas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 661967

Country of ref document: ES